14,15beta-DihydroxyklaineanoneCAS# 137359-82-1 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 137359-82-1 | SDF | Download SDF |
PubChem ID | 10883790 | Appearance | Powder |
Formula | C20H28O8 | M.Wt | 396.43 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC1C(C(C2C3(C(CC4C2(C1(C(C(=O)O4)O)O)C)C(=CC(=O)C3O)C)C)O)O | ||
Standard InChIKey | NWNMAVFXIRDAPM-RELKVJPISA-N | ||
Standard InChI | InChI=1S/C20H28O8/c1-7-5-10(21)15(24)18(3)9(7)6-11-19(4)14(18)13(23)12(22)8(2)20(19,27)16(25)17(26)28-11/h5,8-9,11-16,22-25,27H,6H2,1-4H3/t8-,9-,11+,12+,13-,14+,15+,16-,18-,19+,20-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 14,15beta-Dihydroxyklaineanone (IC(50) = 5 microM) shows anti-tumor promoting on tumor promoter-induced Epstein-Barr virus activation. 2. 14,15beta-Dihydroxyklaineanone is a plant growth inhibitor. |
14,15beta-Dihydroxyklaineanone Dilution Calculator
14,15beta-Dihydroxyklaineanone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5225 mL | 12.6126 mL | 25.2251 mL | 50.4503 mL | 63.0628 mL |
5 mM | 0.5045 mL | 2.5225 mL | 5.045 mL | 10.0901 mL | 12.6126 mL |
10 mM | 0.2523 mL | 1.2613 mL | 2.5225 mL | 5.045 mL | 6.3063 mL |
50 mM | 0.0505 mL | 0.2523 mL | 0.5045 mL | 1.009 mL | 1.2613 mL |
100 mM | 0.0252 mL | 0.1261 mL | 0.2523 mL | 0.5045 mL | 0.6306 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 1''-O-beta-D-glucopyranosylformoside
Catalog No.:BCN8645
CAS No.:148245-77-6
- (1S,2S)-threo-Honokitriol
Catalog No.:BCN8644
CAS No.:1099687-80-5
- Caesappanin C
Catalog No.:BCN8643
CAS No.:1913319-59-1
- Myrrhone
Catalog No.:BCN8642
CAS No.:183551-83-9
- Lancifodilactone C
Catalog No.:BCN8641
CAS No.:663176-26-9
- Hypaconine
Catalog No.:BCN8640
CAS No.:63238-68-6
- Glabrone
Catalog No.:BCN8639
CAS No.:60008-02-8
- Bruceoside A
Catalog No.:BCN8638
CAS No.:63306-30-9
- Veratrosine
Catalog No.:BCN8637
CAS No.:475-00-3
- (Z)-Aldosecologanin
Catalog No.:BCN8636
CAS No.:82474-97-3
- Dihydrolicoisoflavone
Catalog No.:BCN8635
CAS No.:164163-92-2
- Kushenol S
Catalog No.:BCN8634
CAS No.:254886-72-1
- Nephthenol
Catalog No.:BCN8647
CAS No.:53915-41-6
- Bryodulcosigenin
Catalog No.:BCN8648
CAS No.:4965-97-3
- Euphorbia factor L7b
Catalog No.:BCN8649
CAS No.:93550-95-9
- Nortracheloside
Catalog No.:BCN8650
CAS No.:33464-78-7
- 1-Methyl-6-oxopyridine-3-carboxylic acid
Catalog No.:BCN8651
CAS No.:3719-45-7
- Daidzein diacetate
Catalog No.:BCN8652
CAS No.:3682-01-7
- 11alpha-Methoxysaikosaponin F
Catalog No.:BCN8653
CAS No.:104109-37-7
- Angelicolide
Catalog No.:BCN8654
CAS No.:90826-58-7
- 5-Ethoxy-10-Gingerol
Catalog No.:BCN8655
CAS No.:121771-98-0
- Ginsenoside Rh7
Catalog No.:BCN8656
CAS No.:343780-68-7
- Kanzonol C
Catalog No.:BCN8657
CAS No.:151135-82-9
- Nuezhenidic acid
Catalog No.:BCN8658
CAS No.:183238-67-7
Quassinoids from Eurycoma longifolia as plant growth inhibitors.[Pubmed:11684195]
Phytochemistry. 2001 Nov;58(6):959-62.
Seven quassinoids including a new 12-epi-11-dehydroklaineanone were isolated from the leaves of Eurycoma longifolia (Simaroubaceae) as plant growth inhibitors or related compounds. The strongest activity was found in 14,15beta-Dihydroxyklaineanone.
In vitro anti-tumor promoting and anti-parasitic activities of the quassinoids from Eurycoma longifolia, a medicinal plant in Southeast Asia.[Pubmed:12169407]
J Ethnopharmacol. 2002 Sep;82(1):55-8.
Some quassinoids (1-6) isolated previously as plant growth inhibitors from the leaves of Eurycoma longifolia Jack. (Simaroubaceae) were subjected to in vitro tests on anti-tumor promoting, antischistosomal and plasmodicidal activities. The most active compound for inhibition of tumor promoter-induced Epstein-Barr virus activation (anti-tumor promotion) was 14,15beta-Dihydroxyklaineanone (5, IC(50) = 5 microM). Longilactone (1) gave significant antischistosomal effect at a concentration of 200 microg/ml. 11-Dehydroklaineanone (3) and 15beta-O-acetyl-14-hydroxyklaineanone (6) showed potent plasmodicidal activity (IC(50) = 2 microg/ml). Thus it was suggested that E. longifolia possesses high medicinal values due to the occurrence of a variety of quassinoids.